Human Ultracell V IM |
Human Ultracell V Oral |
Human Citoplacell 3G |
Revercell 3G |
Cellorgane Multi-Complex 3G ![]() |
Androcell 3G |
Biofemin 3G |
Bioenzym 3G |
Celltox 3G |
Mekenz H7 3G |
Cellorgane Man |
Cellorgane Woman |
Formula 1 Skin & Muscle |
Formula 2 Liver |
Formula 3 Heart-Artery-Vein |
Formula 4 Bone-Cartilage |
Formula 5 Kidney - Nephrons |
Formula 6 Lungs |
Formula 7 Brain-Hypothalamus-Pituitary |
Formula 8 Adrenal Gland |
Formula 9 Thymus - Spleen |
Formula 10 Pancreas |
Formula 11 Esophagus-Stomach-Intestines |
Formula 12 Thyroid |
Multiorganic Cellular Revitalization Therapy Man
Oral CELLORGANE MAN
Each 500-mg enteric coated tablet contains:
Opotherapic cell extracts: Embryo / Testes, pituitary gland, adrenal gland, brain, embryoblasts, Thymus, hypothalamus, liver, spleen, bone marrow, pancreas, kidney, lung, arteries, veins, capillaries, heart, spinal cord, muscle, cartilage, skin, eyeballs and mesoderm; Antioxidant enzyme complex: Superoxide dismutase, glutathione peroxidase, glutathione reductase, glutathione transferase; Maltodextrin and stabilizers.
Injectable CELLORGANE MAN
Each 750-mg Lyophilized Vial contains:
Opotherapic cell extracts: Embryo / Testes, Pituitary, Adrenal Gland, Brain, embryoblasts, Thymus, hypothalamus, liver, spleen, bone marrow, pancreas, kidney, lung, arteries, veins, capillaries, heart, spinal cord, muscle, cartilage , skin, eyeballs and mesoderm; stabilizers and Mannitol.
Each 10-ml/250-mg Solvent Vial contains:
Opotherapic cell extracts Placenta 10%, procaine 2%, Sodium chloride 0.9%; Enzyme complex: Superoxide dismutase, glutathione peroxidase, glutathione reductase, glutathione transferase, stabilizers and sufficient sterilized Water for injection.
Intramuscular: 2 ml daily for 5 days, two days off and restart 2 ml daily for 5 days, at the end of the injectable treatment should continue with Oral treatment for at least three months.
Orally: 2 tablets daily for 30 days. The tablets are taken with water always on an empty stomach (30 minutes before eating)Orally: 2 tablets in the morning and 2 tablets (2 x 2) at night for at least six months. The tablets are taken with water always on an empty stomach (30 minutes before eating).
Intramuscular:
2 ml daily for 5 days, two days off and restart 2 ml daily for 5 days, evaluate results and continue with 2 ml daily for 5 days, two days off and restart 2 ml daily for 5 days for a total of 4 treatments of Cellorgane Multi-Complex.
It is suggested to repeat the treatment at 3 months after finishing the first block, having been evaluated by the doctor. At the end of the injectable treatment, continue with Oral treatment of 2 X 2 tablets morning and night for at least three months.
The tablets are taken with water always on an empty stomach (30 minutes before eating)
Note: The tablets are taken in the morning on an empty stomach and at night before dinner (30 minutes before meals).
Intramuscular:
2 ml daily for 5 days, two days off and restart 2 ml daily for 5 days, evaluate results and continue with 2 ml daily for 5 days, two days off and restart 2 ml daily for 5 days. Continue applications making a total of 4 cases.
It is suggested to repeat the treatment at 3 months after finishing the first block, prior assessment by the treating physician.
Orally: 2 Tablets in the morning and 2 tablets (2 x 2) at night for at least six months. The tablets are taken with water always on an empty stomach (30 minutes before eating).
Intramuscular: injecting 2 ml intraday until 5 applications per month for 12 continuous months.
Orally: Take 1 tablet in the morning and one at night (1 X 1) for 12 continuous months.Intramuscular: intraday intramuscular injection of 2 ml each month.
Orally: Take 1 tablet in the morning and one (1 X 1) at night for 12 consecutive months. Begin preventive therapy Cellorgane Multi-Complex® # 1 to end on month #12 with Cellorgane Multi-Complex® man or woman according to gender.
Bronchodilators |
Aminophylline, Theophylline, Tiotropium, albuterol, levalbuterol |
Antihistamines | Loratadine, Desloratadine, cetirizine, levocetirizine |
Antihypertensive and heart failure |
|
Hypoglycemic |
|
Diuretics |
|
Statins | Selective, competitive inhibitors of HMG-CoA reductase: atorvastatin, simvastatin, pravastatin |
Coronary vasodilators |
|
Heart failure | Digitalis: Digoxin |
Venous insufficiency |
|
Alzheimer |
|
Hormone Replacement Therapy | Estrogen, Progesterone, Testosterone, Prasterone, Mesterolone, Fluoxymesterone |
Chemotherapy |
|
Antidepressants |
|
Osteoporosis | Zoledronic acid, bisphosphonates: risedronate, alendronate |
Arthritis, Osteoarthritis, Pain relievers and anti-inflammatory |
|
Osteoarthritis | Chondroitin, Glucosamine |
Anti-anemic | Iron |
Renal impairment | Recombinant erythropoietin, Furosemide, Amino Acids |
Erectile dysfunction (ED) | cyclic GMP-specific phosphodiesterase type 5 (PDE5): Sildenafil |
Immunomodulators | Interferon alfa |
Antibiotics | Beta-lactams, aminoglycosides, cephalosporins, macrolides |
Intestinal motility regulators | Cisapride, metoclopramide, Trimebutine, Pinaverium |
Antacids | Omeprazole, famotidine, pantoprazole, ranitidine |
Stool softeners | Fiber, Sennosides, Docusate |
Digestive enzymes | Bromelain, papain, pepsin, trypsin, lipase, Pancreatin |
Alpha-blockers |
Tamsulosin, terazosin, doxazosin, alfuzosin |
Biocell Ultravital™ researches and develops innovative, 100% natural, pharmaceutical-grade bioproducts, on an exclusive basis worldwide. These products optimise cell nutrition and energy, producing a preventative and curative action which, in addition to treating pre-symptoms and symptoms by means of cell renewal, refuels and corrects the cell structure of tissues and organs, preventing the appearance of the functional stress loads which give rise to poor cell formation, degenerative diseases, and their after-effects.
Product developed under pharmaceutical control according to European CE standards. Made in the EC by Biocell Laboratory France, licensed and authorized by Biocell Ultravital GmbH, Switzerland.
This website is governed by applicable laws and government regulations. Please see our Privacy Policy.
Use of this site constitutes your consent to application of such laws and regulations.
» Home
» Training for Doctors
» Analysis Cellular Aging
» Medical News
» Medical Chat Live
» Clinical Protocos
» Medical Questions
» PDF Brochure
» Contact